These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9506029)

  • 21. Does Tricor cause gallstones?
    Lee T
    Harv Heart Lett; 2008 Jul; 18(11):8. PubMed ID: 18697244
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
    Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
    Bergman AJ; Murphy G; Burke J; Zhao JJ; Valesky R; Liu L; Lasseter KC; He W; Prueksaritanont T; Qiu Y; Hartford A; Vega JM; Paolini JF
    J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
    Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pleiotropic effects of fibric acid derivatives (Lipanthyl-200) among patients with metabolic syndrome].
    Zvenigorodskaia LA; Mel'nikova NV; Bondarenko EIu
    Eksp Klin Gastroenterol; 2007; (1):41-6. PubMed ID: 17547112
    [No Abstract]   [Full Text] [Related]  

  • 26. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):34L-40L. PubMed ID: 19084088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey on the efficacy and tolerability of micronized fenofibrate in patients with dyslipidemia.
    Zhu J; Ye P
    Chin Med J (Engl); 2003 Jun; 116(6):840-3. PubMed ID: 12877791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].
    Ceska R; Stulc T
    Cas Lek Cesk; 2000 Jun; 139(12):369-73. PubMed ID: 10953407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination statin-fibrate therapy: safety aspects.
    Franssen R; Vergeer M; Stroes ES; Kastelein JJ
    Diabetes Obes Metab; 2009 Feb; 11(2):89-94. PubMed ID: 18518891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic polymyositis: differential diagnosis of hypothyroid myopathy].
    Labauge P; Figarella-Branger D; Pellissier JF
    Ann Med Interne (Paris); 1996; 147(7):526-7. PubMed ID: 9092370
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study.
    Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL
    Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myopathy caused by fenofibrate].
    Solsona L; Coll J; Ariza A; Olivé A
    Med Clin (Barc); 1991 Nov; 97(17):677. PubMed ID: 1762464
    [No Abstract]   [Full Text] [Related]  

  • 36. Pediatric hypothyroidism presenting with a polymyositis-like syndrome and increased creatinine: report of three cases.
    Sbrocchi AM; Chédeville G; Scuccimarri R; Duffy CM; Krishnamoorthy P
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):89-92. PubMed ID: 18404977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new case of polymyositis caused by tiopronin in rheumatoid arthritis, confirmed by histology].
    Menegale G; Govoni M; Scaramelli M; Caruso G; Trotta F
    Rev Rhum Ed Fr; 1994; 61(7-8):565-6. PubMed ID: 7833898
    [No Abstract]   [Full Text] [Related]  

  • 38. [Muscular toxicity of antilipemic agents revealed during the course of hypothyroidism].
    Prudhomme F; Jacotot B
    Presse Med; 2003 Jun; 32(22):1031-2. PubMed ID: 12894778
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypothyroidism and muscular dystrophy. Apropos of a case].
    Meykadeh F; Wyler C
    Rev Med Suisse Romande; 1965 Sep; 85(9):632-9. PubMed ID: 5851759
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tiopronin-induced polymyositis confirmed by histology].
    Koeger AC; Rozenberg S; Chaibi P; Camus JP; Bourgeois P
    Rev Rhum Ed Fr; 1993 Jan; 60(1):78-9. PubMed ID: 8242034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.